Learning Objectives:

1. Outline MRI modalities used in clinical care and research for ataxias

2. Describe the potential uses of imaging biomarkers/surrogate markers in ataxia trials

3. Summarize the steps needed to validate imaging outcomes for clinical research and therapeutic trials

Session date: 
04/12/2024 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Dr. Guilin Oz